
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1441670-89-8 |
| Catalog No. | 2A-1168276 |
| Chinese Name | (6S)-6-[5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-羧酸叔丁酯 |
| Synonyms | Exact Mass 541.117615; LogP 5.49; Index of Refraction 1.665; InChIKey CZEZIZZCMWUQHO-QFIPXVFZSA-N; Synonyms |
| Molecular Formula | C27H26BrF2N3O2 |
| Molecular Weight | 542.415 |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 681.1±55.0 °C at 760 mmHg |
| Storage Condition | 2-8°C, dry and sealed |
| PubChem ID | 250185111 |
| SMILES | CC(C)(C)OC(=O)N1CC2(CC2)CC1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(Br)ccc2-3)[nH]1 |
| InChI | InChI=1S/C27H26BrF2N3O2/c1-25(2,3)35-24(34)33-14-26(8-9-26)12-22(33)23-31-13-21(32-23)15-4-6-17-18-7-5-16(28)11-20(18)27(29,30)19(17)10-15/h4-7,10-11,13,22H,8-9,12,14H2,1-3H3,(H,31,32)/t22-/m0/s1 |
| InChI Key | CZEZIZZCMWUQHO-QFIPXVFZSA-N |
| Transport Info | Product name: (S)-6-(5-(7-bromo-9,9-difluoren-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylic acid |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| N-acylamino linagliptin-((1-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)urea)) | 2A-1167671 | 2A-1167671 |
| Efavirenz Enantiomer- (4R)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one | 154801-74-8 | 2A-1167912 |
| 2-AMino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetaMide (ClonazepaM IMpurity) | 17714-02-2 | 2A-1168070 |
| Ledipasvir (acetone) | 1441674-54-9 | 2A-1168273 |
| Ledipasvir interMediate | 1256388-50-7 | 2A-1168275 |
| ledipasvir interMediate | 1256387-87-7 | 2A-1168277 |
| Pantoprazole sodium sesquihydrate | 164579-32-2 | 2A-4168297 |
| 6-beta-Fluoro-triamcinolone-acetonide Acetate | 67438-37-3 | 2A-1168310 |
| Velpatasvir intermediate | 1378391-45-7 | 2A-1168434 |
| ledipasvir interMediate | 1256393-27-7 | 2A-1168441 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA